Ahmet Gül

Research.com Recognitions

• The Science Academy Society of Turkey - Bilim Akademisi Romatology

Overview

Best Publications

• Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

  Frédéric A. Houssiau;Carlos Vasconcelos;David D'Cruz;Gian Domenico Sebastiani

  1315
  Citations

• EULAR recommendations for the management of Behçet disease

  G Hatemi;A Silman;D Bang;B Bodaghi

  979
  Citations

• Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease

  Elaine F. Remmers;Fulya Cosan;Yohei Kirino;Michael J. Ombrello

  761
  Citations

• 2018 update of the EULAR recommendations for the management of Behçet’s syndrome

  Gulen Hatemi;Robin Christensen;Dongsik Bang;Bahram Bodaghi

  644
  Citations

• Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease

  Qing Zhou;Hongying Wang;Daniella M. Schwartz;Monique Stoffels

  622
  Citations

• Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1

  Yohei Kirino;George Bertsias;George Bertsias;Yoshiaki Ishigatsubo;Nobuhisa Mizuki

  603
  Citations

• The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

  Frédéric Houssiau;C Vasconcelos;D D'Cruz;G D Sebastiani

  589
  Citations

• Classification criteria for autoinflammatory recurrent fevers

  Marco Gattorno;Michael Hofer;Silvia Federici;Federica Vanoni

  522
  Citations

• Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial

  Frédéric A Houssiau;Carlos Vasconcelos;David D'Cruz;Gian Domenico Sebastiani

  485
  Citations

• Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

  Fabrizio De Benedetti;Marco Gattorno;Jordi Anton;Eldad Ben-Chetrit

  482
  Citations

• Prevalence of Behçet's disease in Istanbul, Turkey.

  Gülsevim Azizlerli;Afet Akdağ Köse;Rifkiye Sarica;Ahmet Gül

  475
  Citations

• Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations

  P. P. Sfikakis;N. Markomichelakis;E. Alpsoy;S. Assaad-Khalil

  421
  Citations

• Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

  J L Mege;N Dilsen;V Sanguedolce;A Gul

  415
  Citations

• Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in behçet's disease: An open-label trial

  Ilknur Tugal-Tutkun;Abdulbaki Mudun;Meri Urgancioglu;Sevil Kamali

  408
  Citations

• Behçet's disease: an update on the pathogenesis.

  A Gül

  377
  Citations

• Induced-Pluripotent-Stem-Cell-Derived Primitive Macrophages Provide a Platform for Modeling Tissue-Resident Macrophage Differentiation and Function.

  Kazuyuki Takata;Kazuyuki Takata;Tatsuya Kozaki;Christopher Zhe Wei Lee;Morgane Sonia Thion

  375
  Citations

• Pulmonary manifestations of Behçet's disease.

  F Erkan;A Gül;E Tasali

  315
  Citations

• Familial aggregation of Behçet's disease in Turkey

  Ahmet Gül;Murat Inanç;Lale Öcal;Orhan Aral

  302
  Citations

• Behçet's disease as an autoinflammatory disorder.

  Ahmet Gul

  297
  Citations

• Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study

  Ahmet Gül;Ilknur Tugal-Tutkun;Charles A Dinarello;Leonid Reznikov

  271
  Citations